• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥法妥木单抗成功治疗伴有爱泼斯坦-巴尔病毒感染的髓鞘少突胶质细胞糖蛋白抗体相关疾病:病例系列

Ofatumumab successfully treats myelin oligodendrocyte glycoprotein antibody-associated disease accompanied by Epstein-Barr viral infection: a case series.

作者信息

Min Chen, Zhuajin Bi, Peidong Liu, Ruoyu Li, Ju Liu, Hongbo Liu

机构信息

Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

出版信息

Front Immunol. 2025 Jan 7;15:1510097. doi: 10.3389/fimmu.2024.1510097. eCollection 2024.

DOI:10.3389/fimmu.2024.1510097
PMID:39845958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11753215/
Abstract

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) caused by pathogenic immunoglobulin G antibodies to myelin oligodendrocyte glycoprotein is a rare demyelinating disease of the central nerve system (CNS). The clinical phenotypes of MOGAD include acute disseminated encephalomyelitis, optic neuritis, and transverse myelitis. At present, the mechanism underlying the disease is unknown. Herein, we report two cases of MOGAD accompanied by Epstein-Barr virus (EBV) infection. Both presented inflammation response in the cerebrospinal fluid (CSF), demonstrating elevated level of cell accounts and protein. EBV genomic sequence was also detected in the CSF samples. The patients recovered substantially after 3 months following a combination treatment with methylprednisolone and immunosuppressive therapy with ofatumumab. These cases provide new insight into the production of MOG-IgG and the possible pathological mechanisms underlying MOGAD. The cases also confirm the association with EBV, a virus that infects human B cells and has been proposed to be a trigger for MOGAD. This is the first report on subcutaneous ofatumumab treatment for MOGAD triggered by EBV, suggesting that this is a potentially valuable therapeutic option.

摘要

由针对髓鞘少突胶质细胞糖蛋白的致病性免疫球蛋白G抗体引起的髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD)是一种罕见的中枢神经系统(CNS)脱髓鞘疾病。MOGAD的临床表型包括急性播散性脑脊髓炎、视神经炎和横贯性脊髓炎。目前,该病的发病机制尚不清楚。在此,我们报告2例伴有爱泼斯坦-巴尔病毒(EBV)感染的MOGAD病例。二者脑脊液(CSF)均出现炎症反应,表现为细胞计数和蛋白质水平升高。在CSF样本中也检测到EBV基因组序列。在接受甲泼尼龙和奥法妥木单抗免疫抑制联合治疗3个月后,患者基本康复。这些病例为MOG-IgG的产生及MOGAD潜在的病理机制提供了新的见解。这些病例还证实了与EBV的关联,EBV是一种感染人类B细胞的病毒,有人提出它是MOGAD的触发因素。这是关于皮下注射奥法妥木单抗治疗由EBV引发的MOGAD的首例报告,表明这是一种具有潜在价值治疗选择。

相似文献

1
Ofatumumab successfully treats myelin oligodendrocyte glycoprotein antibody-associated disease accompanied by Epstein-Barr viral infection: a case series.奥法妥木单抗成功治疗伴有爱泼斯坦-巴尔病毒感染的髓鞘少突胶质细胞糖蛋白抗体相关疾病:病例系列
Front Immunol. 2025 Jan 7;15:1510097. doi: 10.3389/fimmu.2024.1510097. eCollection 2024.
2
Epstein-Barr virus infection in patients with MOGAD.视神经脊髓炎谱系疾病(MOGAD)患者的爱泼斯坦-巴尔病毒感染
Mult Scler. 2025 Jan;31(1):117-120. doi: 10.1177/13524585241298065. Epub 2024 Dec 13.
3
Cerebrospinal fluid eosinophils in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease.儿童髓鞘少突胶质细胞糖蛋白抗体相关性疾病中的脑脊液嗜酸性粒细胞。
Mult Scler Relat Disord. 2024 May;85:105526. doi: 10.1016/j.msard.2024.105526. Epub 2024 Mar 9.
4
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management.髓鞘少突胶质细胞糖蛋白抗体相关疾病:疾病病理生理学、诊断和管理的最新见解。
Int J Mol Sci. 2020 Dec 24;22(1):100. doi: 10.3390/ijms22010100.
5
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.患者的脑脊液发现髓鞘少突胶质细胞糖蛋白 (MOG) 抗体。第 1 部分:100 例成年患者 163 次腰椎穿刺的结果。
J Neuroinflammation. 2020 Sep 3;17(1):261. doi: 10.1186/s12974-020-01824-2.
6
Patterns and utility of myelin oligodendrocyte glycoprotein (MOG) antibody testing in cerebrospinal fluid.脑脊液髓鞘少突胶质细胞糖蛋白(MOG)抗体检测的模式和效用。
J Neurol. 2024 May;271(5):2662-2671. doi: 10.1007/s00415-024-12213-7. Epub 2024 Feb 16.
7
Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: a case report.原发性EB病毒感染所致传染性单核细胞增多症后抗髓鞘少突胶质细胞糖蛋白抗体阳性急性播散性脑脊髓炎:一例报告
BMC Neurol. 2017 Apr 19;17(1):76. doi: 10.1186/s12883-017-0858-6.
8
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients.患者脑脊液中髓鞘少突胶质细胞糖蛋白 (MOG) 抗体的发现。第 2 部分:80 例儿科患者 108 次腰椎穿刺的结果。
J Neuroinflammation. 2020 Sep 3;17(1):262. doi: 10.1186/s12974-020-01825-1.
9
E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.欧盟儿科 MOG 合作组共识:第 1 部分-儿童髓鞘少突胶质细胞糖蛋白抗体相关疾病的临床表型分类。
Eur J Paediatr Neurol. 2020 Nov;29:2-13. doi: 10.1016/j.ejpn.2020.10.006. Epub 2020 Nov 4.
10
Clinical characteristics of pediatric and adult myelin oligodendrocyte antibody-associated disease (MOGAD): A single-center study in the Northeast.儿童及成人髓鞘少突胶质细胞抗体相关疾病(MOGAD)的临床特征:一项东北地区的单中心研究
Mult Scler Relat Disord. 2024 Dec;92:105950. doi: 10.1016/j.msard.2024.105950. Epub 2024 Oct 29.

引用本文的文献

1
Myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis: a case report highlighting diagnostic challenges and therapeutic implications.髓鞘少突胶质细胞糖蛋白抗体相关的大脑皮质脑炎:一例报告,突出诊断挑战及治疗意义
Front Immunol. 2025 Jun 18;16:1619807. doi: 10.3389/fimmu.2025.1619807. eCollection 2025.

本文引用的文献

1
Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD)首次发病事件后疾病复发过程的预测因素。
J Neurol Sci. 2024 Mar 15;458:122909. doi: 10.1016/j.jns.2024.122909. Epub 2024 Jan 30.
2
Ofatumumab for the treatment of refractory anti-LGI1 encephalitis with long-term poor blood glucose control in type 1 diabetes.奥法妥木单抗用于治疗1型糖尿病中难治性抗LGI1脑炎合并长期血糖控制不佳的情况。
CNS Neurosci Ther. 2023 Dec;29(12):4172-4174. doi: 10.1111/cns.14416. Epub 2023 Aug 21.
3
Case report: MOG-IgG-associated encephalitis with Epstein-Barr virus infection and Alzheimer's pathologic change in cerebrospinal fluid.
病例报告:伴有爱泼斯坦-巴尔病毒感染及脑脊液中阿尔茨海默病病理改变的MOG-IgG相关脑炎
Front Neurol. 2022 Dec 2;13:1013413. doi: 10.3389/fneur.2022.1013413. eCollection 2022.
4
The long-term outcome of MOGAD: An observational national cohort study of 61 patients.MOGAD 的长期预后:一项观察性全国队列研究,纳入 61 例患者。
Eur J Neurol. 2021 May;28(5):1659-1664. doi: 10.1111/ene.14746. Epub 2021 Feb 19.
5
MOGAD: How It Differs From and Resembles Other Neuroinflammatory Disorders.MOGAD:它与其他神经炎症性疾病的不同之处。
AJR Am J Roentgenol. 2021 Apr;216(4):1031-1039. doi: 10.2214/AJR.20.24061. Epub 2021 Feb 17.
6
The B cell immunobiology that underlies CNS autoantibody-mediated diseases.中枢神经系统自身抗体介导疾病的 B 细胞免疫生物学。
Nat Rev Neurol. 2020 Sep;16(9):481-492. doi: 10.1038/s41582-020-0381-z. Epub 2020 Jul 28.
7
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.利妥昔单抗治疗MOG-IgG相关疾病:一项针对121例患者的国际研究。
Mult Scler Relat Disord. 2020 Sep;44:102251. doi: 10.1016/j.msard.2020.102251. Epub 2020 Jun 2.
8
Follow-up study on Chinese children with relapsing MOG-IgG-associated central nervous system demyelination.复发型髓鞘少突胶质细胞糖蛋白抗体相关中枢神经系统脱髓鞘病患儿的随访研究。
Mult Scler Relat Disord. 2019 Feb;28:4-10. doi: 10.1016/j.msard.2018.12.001. Epub 2018 Dec 3.
9
Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein.抗髓鞘少突胶质细胞糖蛋白人抗体的致病性。
Ann Neurol. 2018 Aug;84(2):315-328. doi: 10.1002/ana.25291. Epub 2018 Sep 9.
10
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.成人中枢神经系统 MOG 自身免疫的临床谱和预后价值:MOGADOR 研究。
Neurology. 2018 May 22;90(21):e1858-e1869. doi: 10.1212/WNL.0000000000005560. Epub 2018 Apr 25.